3/31/2020 Montelukast and Symbicort Drug Interactions - Drugs.

com

Drug Interactions between montelukast and

Symbicort
This report displays the potential drug interactions for the following 2 drugs:
montelukast
Symbicort (budesonide/formoterol)

Interactions between your drugs

Minor budesonide  formoterol

Applies to: Symbicort (budesonide / formoterol) and Symbicort (budesonide / formoterol)

Consumer information for this minor interaction is not currently available. Some minor drug
interactions may not be clinically relevant in all patients. Minor drug interactions do not usually
cause harm or require a change in therapy. However, your healthcare provider can determine
if adjustments to your medications are needed.

For clinical details see professional interaction data.

Drug and food interactions

Moderate budesonide  food

Applies to: Symbicort (budesonide / formoterol)

You should avoid the regular consumption of large amounts of grapefruits and grapefruit juice while
taking budesonide. Grapefruit can raise the levels of budesonide in your body and lead to increased
side effects. Do not increase or decrease the amount of grapefruit products in your diet without first
talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the
recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a
specific individual is difficult to determine. Always consult your healthcare provider before
https://www.drugs.com/drug-interactions/montelukast-with-symbicort-1654-0-432-2530.html 1/2
3/31/2020 Montelukast and Symbicort Drug Interactions - Drugs.com

starting or stopping any medication.

Major Highly clinically significant. Avoid combinations; the risk of the interaction
outweighs the benefit.

Moderate Moderately clinically significant. Usually avoid combinations; use it only under
special circumstances.

Minor Minimally clinically significant. Minimize risk; assess risk and consider an
alternative drug, take steps to circumvent the interaction risk and/or institute a
monitoring plan.

Unknown No interaction information available.

Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to
your personal circumstances.

https://www.drugs.com/drug-interactions/montelukast-with-symbicort-1654-0-432-2530.html 2/2